Leadless cardiac ventricular pacing using helix fixation: Step-by-step guide to implantation
Balint Laczay1, Jose Aguilera1, Daniel J Cantillon1
1Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Journal of Cardiovascular Electrophysiology
|December 21, 2022
Summary
The new AVEIR VR leadless pacemaker system offers a safe alternative to traditional pacemakers. This review details its implantation procedure, from patient selection to managing complications.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Leadless cardiac pacemakers present an alternative to conventional transvenous systems.
- The AVEIR VR system, a novel helix-based active fixation leadless pacemaker, has received FDA approval.
- This technology aims to improve pacing delivery and patient outcomes.
Approach:
- This review synthesizes case data from primary operators.
- It provides a comprehensive, step-by-step guide for healthcare providers.
- The focus is on practical aspects of implantation and patient management.
Key Points:
- The review covers crucial aspects including patient selection and pre-procedural planning.
- Detailed implantation techniques, implant site evaluation, and troubleshooting are discussed.
- Potential short- and long-term complications and future directions are also addressed.
Conclusions:
- The helix-based active fixation leadless pacemaker system is a safe and effective pacing solution.
- It offers a viable alternative to transvenous pacemaker systems.
- This guide facilitates successful implantation and management of leadless pacing.
